Concerns have been raised throughout the nation as a result of the JN.1 sub-variant of SARS-COV2 epidemic, and the Union government has ordered states to submit samples of all Covid-19 test swabs for a complete genome sequencing in an effort to increase monitoring for any potentially dangerous virus variants.
Kerala, Karnataka, Tamil Nadu, Maharashtra, Goa, Puducherry, Gujarat, Telangana, Punjab, and Delhi are among the afflicted states in India where there has been a little spike in cases. States have taken preventative action by increasing their readiness and enacting personal surveillance policies.
With only modest symptoms, almost 93% of people afflicted are staying at home and solitary. Only 0.1% of patients receiving care at different hospitals around the nation are on a ventilator, 1.2% are admitted to an intensive care unit (ICU), and 0.6% are on oxygen assistance, according to official data.
According to the World Health Organization (WHO), there is no proof that JN.1 poses a greater danger to public health than other currently circulating variants, even though it is classed as a Variant of Interest (VOI). According to the available data, the UN health body also stated that vaccinations are capable of preventing serious illness and even death.
